130 related articles for article (PubMed ID: 15930276)
21. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line.
Elwood NJ; Cook WD; Metcalf D; Begley CG
Oncogene; 1993 Nov; 8(11):3093-101. PubMed ID: 8414511
[TBL] [Abstract][Full Text] [Related]
22. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.
Ikegaki N; Gotoh T; Kung B; Riceberg JS; Kim DY; Zhao H; Rappaport EF; Hicks SL; Seeger RC; Tang XX
Clin Cancer Res; 2007 Oct; 13(20):6001-9. PubMed ID: 17947461
[TBL] [Abstract][Full Text] [Related]
23. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
24. N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma.
Hossain MS; Ozaki T; Wang H; Nakagawa A; Takenobu H; Ohira M; Kamijo T; Nakagawara A
Oncogene; 2008 Oct; 27(46):6075-82. PubMed ID: 18591937
[TBL] [Abstract][Full Text] [Related]
25. A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma.
Watt F; Watanabe R; Yang W; Agren N; Arvidsson Y; Funa K
Cancer Gene Ther; 2007 Mar; 14(3):287-96. PubMed ID: 17124508
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.
Machida T; Fujita T; Ooo ML; Ohira M; Isogai E; Mihara M; Hirato J; Tomotsune D; Hirata T; Fujimori M; Adachi W; Nakagawara A
Oncogene; 2006 Mar; 25(13):1931-42. PubMed ID: 16288218
[TBL] [Abstract][Full Text] [Related]
27. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.
Wang N; Lin KK; Lu Z; Lam KS; Newton R; Xu X; Yu Z; Gill GN; Andersen B
Oncogene; 2007 Sep; 26(44):6431-41. PubMed ID: 17452977
[TBL] [Abstract][Full Text] [Related]
28. The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.
Hecht M; Schulte JH; Eggert A; Wilting J; Schweigerer L
Carcinogenesis; 2005 Dec; 26(12):2105-15. PubMed ID: 16051641
[TBL] [Abstract][Full Text] [Related]
29. HIF2 alpha reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma.
Favier J; Lapointe S; Maliba R; Sirois MG
BMC Cancer; 2007 Jul; 7():139. PubMed ID: 17655754
[TBL] [Abstract][Full Text] [Related]
30. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
[TBL] [Abstract][Full Text] [Related]
31. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
32. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
Löfstedt T; Fredlund E; Noguera R; Navarro S; Holmquist-Mengelbier L; Beckman S; Påhlman S; Axelson H
Exp Cell Res; 2009 Jul; 315(11):1924-36. PubMed ID: 19254710
[TBL] [Abstract][Full Text] [Related]
33. ARID3B induces malignant transformation of mouse embryonic fibroblasts and is strongly associated with malignant neuroblastoma.
Kobayashi K; Era T; Takebe A; Jakt LM; Nishikawa S
Cancer Res; 2006 Sep; 66(17):8331-6. PubMed ID: 16951138
[TBL] [Abstract][Full Text] [Related]
34. Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation.
Ciarapica R; Annibali D; Raimondi L; Savino M; Nasi S; Rota R
Oncogene; 2009 Apr; 28(17):1881-91. PubMed ID: 19330020
[TBL] [Abstract][Full Text] [Related]
35. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
[TBL] [Abstract][Full Text] [Related]
36. Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms.
Tong QS; Jiang GS; Zheng LD; Tang ST; Cai JB; Liu Y; Zeng FQ; Dong JH
Acta Pharmacol Sin; 2008 Jul; 29(7):861-9. PubMed ID: 18565287
[TBL] [Abstract][Full Text] [Related]
37. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
38. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas.
Gestblom C; Hoehner JC; Hedborg F; Sandstedt B; Påhlman S
Am J Pathol; 1997 Jan; 150(1):107-17. PubMed ID: 9006328
[TBL] [Abstract][Full Text] [Related]
39. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
[TBL] [Abstract][Full Text] [Related]
40. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
